Biomed Israel 2025
NeuroKaire joined Biomed Israel 2025 to showcase our AI-powered brain-in-a-dish platform. CEO Dr. Talia Cohen Solal spoke on a panel about breakthroughs in neurotech and how our technology is personalizing depression treatment and advancing CNS drug development.
On May 20, 2025, NeuroKaire took part in Biomed Israel 2025, a premier international conference spotlighting cutting-edge developments in healthcare and biotechnology.
Our CEO & Co-founder, Dr. Talia Cohen Solal, spoke during the session “Rewiring the Brain: Breakthroughs in Neurotech and Neuromodulation,” moderated by Barry Greene and Dr. Iris Grossman, PhD.
Talia presented how NeuroKaire’s AI-driven brain-in-a-dish platform is being used to personalize treatment for depression and advance CNS drug development. The session brought together industry leaders and innovators for a powerful conversation about the future of neurotechnology and its clinical impact.
We extend our thanks to Ruti Alon for organizing this meaningful discussion and creating space for thought leadership at the intersection of neuroscience, AI, and precision medicine.
Topics Covered:
- AI-powered brain-in-a-dish technology
- Personalization of depression treatment
- CNS drug development acceleration
- Neurotech innovation and neuromodulation
Schedule a Meet & Greet
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel